Biosion, Inc. 3
3 · Aclaris Therapeutics, Inc. · Filed Nov 25, 2024
Insider Transaction Report
Form 3
Biosion, Inc.
10% Owner
Holdings
Warrants (right to buy)
Exercise: $0.00From: 2024-11-18→ Common Stock (11,281,985 underlying)
Footnotes (1)
- [F1]On November 18, 2024, Aclaris Therapeutics, Inc. ("Aclaris") and Biosion, Inc. ("Biosion") entered into a Common Stock Purchase Warrant (the "Warrant"). Pursuant to the Warrant, Biosion, its designee or its permitted assigns, upon meeting certain terms and conditions of the Warrant, is entitled to exercise the warrant for up to 11,281,985 shares of Aclaris Common Stock. The Warrant was exercisable as of November, 18 2024 and may be exercised until the date on which the Warrant is exercised in full.